KPWS
REGN icon

Kestra Private Wealth Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Kestra Private Wealth Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$767K Sell
993
-52
-5% -$39.8K 0.01% 977
2025
Q4 		$806K Sell
1,045
-9
-0.9% -$6.11K 0.01% 901
2025
Q3 		$592K Sell
1,054
-557
-35% -$315K 0.01% 1024
2025
Q2 		$846K Sell
1,611
-447
-22% -$249K 0.01% 804
2025
Q1 		$1.31M Buy
2,058
+132
+7% +$90.8K 0.02% 586
2024
Q4 		$1.37M Buy
1,926
+220
+13% +$185K 0.02% 539
2024
Q3 		$1.79M Buy
1,706
+331
+24% +$368K 0.03% 452
2024
Q2 		$1.44M Sell
1,375
-377
-22% -$365K 0.03% 475
2024
Q1 		$1.69M Sell
1,752
-20
-1% -$19K 0.04% 419
2023
Q4 		$1.56M Buy
1,772
+292
+20% +$240K 0.04% 420
2023
Q3 		$1.22M Buy
1,480
+102
+7% +$80.2K 0.04% 408
2023
Q2 		$990K Buy
1,378
+119
+9% +$91.7K 0.03% 442
2023
Q1 		$1.03M Buy
1,259
+349
+38% +$263K 0.04% 399
2022
Q4 		$657K Buy
910
+421
+86% +$311K 0.03% 457
2022
Q3 		$337K Sell
489
-216
-31% -$136K 0.02% 611
2022
Q2 		$417K Sell
705
-188
-21% -$122K 0.02% 556
2022
Q1 		$624K Sell
893
-193
-18% -$122K 0.03% 504
2021
Q4 		$686K Buy
1,086
+456
+72% +$280K 0.03% 493
2021
Q3 		$381K Buy
630
+16
+3% +$9.93K 0.02% 619
2021
Q2 		$343K Sell
614
-50
-8% -$25.3K 0.02% 623
2021
Q1 		$314K Buy
+664
New +$323K 0.02% 591

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kestra Private Wealth Services's REGN Position: Q1 2026 in Review

Kestra Private Wealth Services reduced its Regeneron Pharmaceuticals (REGN) stake by 5% in Q1 2026, selling an estimated $39.8K and leaving 993 shares worth $767K. The position accounts for 0.01% of the portfolio, ranked #977.

Kestra Private Wealth Services first reported a position in REGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.79M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Kestra Private Wealth Services held 993 shares of Regeneron Pharmaceuticals worth $767K as of Q1 2026.
  • Kestra Private Wealth Services sold 52 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $39.8K.
  • Regeneron Pharmaceuticals made up 0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #977 holding.
  • Kestra Private Wealth Services first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Kestra Private Wealth Services's Regeneron Pharmaceuticals position peaked at $1.79M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.